Product Spotlight

Monday, April 25, 2016
IntraDerm Pharmaceuticals’ Ceramax is a new prescription topical skincare preparation for the relief and management of symptoms associated with various dermatoses.
Tuesday, November 17, 2015
Finacea Foam, 15% is a recently FDA-approved topical treatment for patients experiencing the inflammatory papules and pustules of mild to moderate rosacea.
Thursday, October 15, 2015
Topicort Cream 0.05% and Ointment 0.05% are examples of class C steroids for the treatment of inflammatory and pruritic skin diseases.
Monday, September 21, 2015
Celacyn improves the appearance of scars and relieves the associated itching and pain.
Thursday, July 16, 2015
Sitavig’s unique vehicle and delivery system offers a new treatment option for patients experiencing cold sores.
Tuesday, June 16, 2015
Desonate Gel 0.05% is a low potency topical gel formulated in a proprietary water-based hydrogel vehicle FDA approved for the treatment of atopic dermatitis.
Wednesday, May 20, 2015
The 3-step Obagi360 System works to address the early signs of skin aging and helps to protect against future skin damage.  
Friday, April 17, 2015
Halo provides a safe, tunable and effective long-term hybrid option for laser resurfacing treatments.  
Wednesday, October 22, 2014
JUVÉDERM VOLUMA™ XC is the first and only FDA-approved hyaluronic acid filler to correct age-related volume loss in the cheek area in adults.
Wednesday, September 17, 2014
The FDA approved Erivedge (vismodegib) in January 2012 as a first-in-class hedgehog pathway inhibitor indicated for the treatment of adults with metastatic basal cell carcinoma (BCC), or with locally advanced BCC that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.